Stay updated on DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial
Sign up to get notified when there's something new on the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page.

Latest updates to the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page
- Check6 days agoChange DetectedA new page revision (v3.5.5) replaces the previous v3.5.4, indicating a minor update to the page’s version history and not a substantive change to the study details.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 was removed, updating the page's revision history. This change reflects a newer page version rather than any alteration to the study details themselves.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page’s footer/update indicator changed from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a website release/version update rather than a change to the study record details.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded revision v3.5.2 and removed revision v3.5.0.SummaryDifference0.1%

- Check70 days agoChange DetectedAdds a related disease topic, Hereditary factor IX deficiency, and links to Genetic and Rare Diseases Information Center resources on the study page.SummaryDifference0.2%

- Check77 days agoChange DetectedHemophilia B is removed from the page content. The Genetic and Rare Diseases Information Center resource link in Resources is removed.SummaryDifference0.2%

Stay in the know with updates to DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page.